Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REX Trial: Remifentanil for Extubation Cough
NCT03132519Phase 4Completed
- Sponsor
- Fundación Valle del Lili
- Start
- Oct 2013
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remifentanil in cough and hypertension (HTN) (6 arms), sponsored by Fundación Valle del Lili. Primary endpoint: Presence and intensity of cough. Started Oct 2013; status: completed.
02
Drugs
remifentanil
03
Conditions
coughhypertension (HTN)
Beyond the preview
Go deeper on NCT03132519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03132519.